Modeling Hematopoiesis in MDS and AML with QSP
Discover a mechanistic QSP platform model of hematopoiesis to evaluate therapies in MDS and AML,…
Certara2026 年 5 月 1 日
IO Simulator: A QSP Platform for Immuno-Oncology
This poster showcases how IO Simulator predicts immunotherapy response and supports combination design and biomarker…
Certara2026 年 4 月 30 日
From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development
Explore Certara’s insights from QSPC 2026, including virtual patients, regulatory adoption, AI in QSP, and…
Certara2026 年 4 月 28 日
Top 10 Benefits of Simcyp® Simulator for Drug Development
JTVCdGVhbV9qdW1wX2xpc3QlNUQ= 2026 年 4 月 23 日 Physiologically based pharmacokinetic (PBPK) modeling has evolved from an emerging methodology…
Certara2026 年 4 月 23 日
ADC Dose Optimization: Applying Model-Informed Strategies in Development
Explore ADC dose optimization using model-informed strategies to balance efficacy and safety across antibody drug…
Certara2026 年 4 月 22 日
Extending the Value of Antibody–Drug Conjugates: Model-Informed Labeling, Expansion, and Market Access
Learn how model-informed strategies support ADC labeling, dose optimization, and market access through integrated evidence…
Certara2026 年 4 月 10 日
How Certara Enabled Fruquintinib FDA Approval for Metastatic Colorectal Cancer
HUTCHMED was preparing a New Drug Application (NDA) submission for FRUZAQLA® (fruquintinib) a drug developed…
Certara2026 年 4 月 7 日
Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations
Watch this on-demand webinar to learn how the final ICH M15 guidance is shaping Model-Informed…
Certara2026 年 4 月 2 日
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics
This review article examines the development of radiopharmaceutical imaging agents and radioligand therapies for pediatric…
Certara2026 年 3 月 26 日
Portfolio Prioritization for Large and Small Pharma Using Early-Stage Biosimulation
Learn how early-stage biosimulation and mechanistic modeling enable smarter portfolio prioritization before IND-enabling studies. Watch…
Certara2026 年 3 月 25 日
